Pharma Focus Asia

Pharma Focus Asia Pharma Focus Asia - Magazine for Pharma Industry Leaders
https://www.linkedin.com/company/pharmafocusasia/ Ltd.. Pharma Focus Asia offers . . .

Pharma Focus Asia is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies. Pharma Focus Asia covers important issues and trends shaping the future of the pharma industry across Asia and rest of the world. Dedicated, reliable and accurate coverage

of the industry’s progress and
Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:

Strategy
Research and Development
Manufacturing
Clinical Trials
Information Technology


The one-stop pharma destination www.pharmafocusasia.com features complete content from the Pharma Focus Asia magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership

The magazine’s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on Asia, Pharma Focus Asia reaches out to the key industry leaders across Asia, Europe and the Americas.

Behind every safe pharmaceutical product, there’s something we don’t often talk about—water.Not just any water, but high...
27/04/2026

Behind every safe pharmaceutical product, there’s something we don’t often talk about—water.

Not just any water, but highly controlled, constantly monitored systems that need to perform without fail. In the latest issue (62) of Pharma Focus Asia, Kok Fong Tiyo from Veolia explains how Process Analytical Technology (PAT) is helping teams move from manual checks and uncertainty to real-time visibility and confidence.

Imagine being able to catch a problem before it becomes a disruption. Or reducing downtime because your systems can “tell” you what they need. That’s the difference digital water systems are starting to make.

It’s a step toward safer processes, less waste, and more resilient manufacturing.

Read the full story in Pharma Focus Asia: https://www.pharmafocusasia.com/expert-corner/next-generation-water-systems-in-pharma

Download the latest issue from our website today: https://www.pharmafocusasia.com/magazine

AI in pharma is evolving fast—and agentic AI is leading the next big shift.In Pharma Focus Asia, Issue 62, Jason Bryant ...
24/04/2026

AI in pharma is evolving fast—and agentic AI is leading the next big shift.

In Pharma Focus Asia, Issue 62, Jason Bryant (VP, Product Management AI & Data, ArisGlobal) explains how autonomous, goal-driven AI agents can transform everything from safety reporting to regulatory compliance.

Imagine systems that don’t just assist but think, act, and adapt—helping teams focus on critical decisions while improving speed, accuracy, and outcomes.

This is about more than efficiency—it’s about reshaping how pharma delivers value to patients.

Get your copy of the latest issue: https://www.pharmafocusasia.com/magazine

Read the full article today on our website: https://www.pharmafocusasia.com/information-technology/assessing-the-merits-of-agentic-ai

AI can generate impressive molecular predictions—but how often do they truly match reality?That’s the question explored ...
23/04/2026

AI can generate impressive molecular predictions—but how often do they truly match reality?

That’s the question explored by Robin Röhm, CEO & Co-Founder of Apheris, in the latest Pharma Focus Asia (Issue 62).

He walks through how co-folding AI models are being used in drug discovery today, why results can sometimes be misleading, and how fine-tuning with real, proprietary data helps bridge that gap. The article also looks at how pharma companies are beginning to collaborate securely using federated learning—improving models without sharing sensitive information.

It’s a thoughtful, practical take on making AI actually useful in pharma R&D.

Download the magazine: https://www.pharmafocusasia.com/magazine

Read the full article on our website: https://www.pharmafocusasia.com/information-technology/fine-tuning-ai-models-for-molecular

There’s always something new happening in pharma—and it’s easy to miss what truly matters.That’s why Pharma Focus Asia’s...
22/04/2026

There’s always something new happening in pharma—and it’s easy to miss what truly matters.

That’s why Pharma Focus Asia’s newsletter brings everything together for you. Thoughtful ARTICLES, expert INTERVIEWS, industry NEWS, TECHNO TRENDS, RESEARCH INSIGHTS, and more are curated for busy professionals who want clarity, not noise.

Whether you’re in research, leadership, or operations, it’s a simple way to stay connected to the bigger picture.
https://industry.pharmafocusasia.com/e-newsletters/1776747797-Apr-26.html

📩 Subscribe now and share it with your team or peers

Visit our website to get started: https://www.pharmafocusasia.com/subscribe

AI in pharma is changing—but what really matters is this: can clinicians trust it?According to Jinge Wu (UCL) and Fengli...
21/04/2026

AI in pharma is changing—but what really matters is this: can clinicians trust it?

According to Jinge Wu (UCL) and Fenglin Liu (Oxford University Hospitals NHS Foundation Trust), the answer is finally becoming “yes.”

Instead of relying on guesswork, new AI systems are built on real clinical evidence. They connect the dots between diseases, symptoms, and treatments—and actually show where their recommendations come from.

That means fewer risks, clearer decisions, and more confidence in using AI at the bedside.

It’s a big step forward—not just for technology, but for patient care.

👉 Want to see how this works in practice? Visit our website and explore our solutions:
https://www.pharmafocusasia.com/interviews/from-hallucinations-to-evidence

There’s a lot happening in the world of antibody therapeutics right now.New formats like ADCs and antibody–oligonucleoti...
20/04/2026

There’s a lot happening in the world of antibody therapeutics right now.

New formats like ADCs and antibody–oligonucleotide conjugates are opening doors—but they also bring new challenges in analysis and delivery, especially when targeting the brain.

In this webinar, Prof. Yuji Ito breaks down how AccumuBrain and AccumBody platforms are being used, along with real-world analytical approaches that support these complex therapies.

🗓 April 24, 2026
⏰ 11:30 a.m. IST

Join live or watch later—whatever works for you.

Sign up here: https://industry.pharmafocusasia.com/clientemailblast/1776342504-Agilent-Technologies.html

Some of the most exciting progress in healthcare today is happening in cell and gene therapy—and APAC is right in the mi...
17/04/2026

Some of the most exciting progress in healthcare today is happening in cell and gene therapy—and APAC is right in the middle of it.

In Pharma Focus Asia Issue 62, Wei Xia ANG (Senior Regulatory Compliance Lead, Cytiva) talks about what’s really going on behind the scenes. It’s not just innovation—it’s the hard work of aligning regulations, solving manufacturing challenges, and finding ways to get treatments to patients faster.

It’s a reminder that progress in healthcare is as much about collaboration as it is about science.

You can read the full article: https://www.pharmafocusasia.com/manufacturing/navigating-the-future-the-regulatory

Download the issue here: https://www.pharmafocusasia.com/magazine

There’s a quiet transformation happening in the pharmaceutical world—and it’s changing everything.Innovation is no longe...
16/04/2026

There’s a quiet transformation happening in the pharmaceutical world—and it’s changing everything.

Innovation is no longer limited to big pharma labs. Today, small biotech companies, AI technologies, and global collaborations are working together to bring new treatments to life faster than ever before.

In Pharma Focus Asia Issue 62, Lavinia Woodward from Excelra explains how this shift is reshaping the future of drug discovery—and why collaboration is becoming more powerful than control.

It’s not just about making medicines anymore. It’s about how quickly we can get them to the people who need them most.

Read the full story—https://www.pharmafocusasia.com/research-development/from-monoliths-to-ecosystems

Download the latest issue now: https://www.pharmafocusasia.com/magazine

Not every aspiring scientist has access to a fully equipped lab, but what if they didn’t need one?In Pharma Focus Asia –...
15/04/2026

Not every aspiring scientist has access to a fully equipped lab, but what if they didn’t need one?

In Pharma Focus Asia – Issue 62, Stephen Hilton and Blanka Hilton show how digital twin labs and AI-powered avatars are helping people learn complex pharmaceutical skills from anywhere in the world.

Imagine practicing HPLC techniques, troubleshooting experiments, or understanding flow chemistry—all in a virtual space, guided step-by-step in your own language.

This isn’t just technology—it’s opportunity. It’s about making pharma education more human, more inclusive, and more accessible for everyone.

🌍 A future where talent matters more than location is already here.

Download the latest issue: https://www.pharmafocusasia.com/magazine

Read the full article on our website: https://www.pharmafocusasia.com/research-development/redefining-pharmaceutical-research

Not every medicine that’s made reaches a patient.Sometimes, it’s exposed to the wrong temperature.Sometimes, it’s delaye...
14/04/2026

Not every medicine that’s made reaches a patient.

Sometimes, it’s exposed to the wrong temperature.
Sometimes, it’s delayed in transit.
Sometimes, it simply doesn’t make it in time.

In 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐬𝐢𝐚 (𝐈𝐬𝐬𝐮𝐞 𝟔𝟐), Swarup Bose, Founder & CEO, Celcius Logistics, explains why this happens—and how smarter logistics can change the story.

From cold chain gaps to last-mile challenges, the problem is real. But so are the solutions—AI, IoT, and better infrastructure are helping ensure medicines reach people safely and when they’re needed most.

Because every dose matters.

Download the latest issue: https://www.pharmafocusasia.com/magazine

Read more: https://www.pharmafocusasia.com/strategy/why-pharma-products-still-go-to-waste

🌍 Visit our website to see how we’re making pharma logistics more reliable and patient-focused.

Sometimes, smaller really is better.Miniproteins—tiny engineered molecules—are showing real promise in solving challenge...
13/04/2026

Sometimes, smaller really is better.

Miniproteins—tiny engineered molecules—are showing real promise in solving challenges that traditional antibody drugs can’t. Think better access to hard-to-reach tissues, simpler manufacturing, and even the possibility of pills instead of injections.

Victor H. Bustos, Ph.D., and Alena Romanova from Ordaos Bio break it down in a way that connects science with real-world impact—especially for patients living with chronic diseases.

It’s exciting to see where this is heading.

👉 Visit our website to read more: https://www.pharmafocusasia.com/articles/the-therapeutics-landscape-of-miniproteins

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Website

Alerts

Be the first to know and let us send you an email when Pharma Focus Asia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pharma Focus Asia:

Shortcuts

Share

Category